Abstract: The present teaching relates to a method and a system for advertising. The method obtains information about a conversion associated with an advertisement and generates with respect to the conversion, an operational smart attribution evaluation package (SAEP). The SAEP includes a conversion parameter and a reward. The method transmits the SAEP to a platform to be posted, and thereafter receives from the SAEP, an indication of an entity which is estimated to be associated with the conversion and to which the reward is to be allocated. The entity is determined by the SAEP based on the conversion parameter and information from a plurality of entities that displayed the advertisement.

Abstract: The present teaching relates to method and system for advertising. The method obtains information related to an operational smart attribution evaluation package (SAEP) posted on a platform. The SAEP is related to a conversion associated with an advertisement displayed by a plurality of entities. The method parses the SAEP to obtain a conversion parameter, and generates a claim for the conversion based on the conversion parameter and information related to the advertisement, if the advertisement was previously displayed. Further, the method transmits the generated claim to the SAEP to be evaluated whether a reward is to be allocated.

Abstract: The present teaching relates to a method and a system for advertising. The method obtains information about a conversion associated with an advertisement and generates with respect to the conversion, an operational smart attribution evaluation package (SAEP). The SAEP includes a conversion parameter and a reward. The method transmits the SAEP to a platform to be posted, and thereafter receives from the SAEP, an indication of an entity which is estimated to be associated with the conversion and to which the reward is to be allocated. The entity is determined by the SAEP based on the conversion parameter and information from a plurality of entities that displayed the advertisement.

Abstract: The present teaching relates to method and system for evaluating a conversion. The method extracts meta-information including a conversion parameter and a reward. The meta-information corresponds to a conversion associated with an advertisement displayed previously by a plurality of entities. The method receives a plurality of claims for the conversion from one or more entities, and selects a claim corresponding to an entity from the plurality of claims based on the conversion parameter and information included in the plurality of claims. Further, the method transmits information related to the selected claim.

Abstract: The present teaching relates to method and system for advertising. The method obtains information related to an operational smart attribution evaluation package (SAEP) posted on a platform. The SAEP is related to a conversion associated with an advertisement displayed by a plurality of entities. The method parses the SAEP to obtain a conversion parameter, and generates a claim for the conversion based on the conversion parameter and information related to the advertisement, if the advertisement was previously displayed. Further, the method transmits the generated claim to the SAEP to be evaluated whether a reward is to be allocated.

Abstract: The present teaching relates to method and system for evaluating a conversion. The method extracts meta-information including a conversion parameter and a reward. The meta-information corresponds to a conversion associated with an advertisement displayed previously by a plurality of entities. The method receives a plurality of claims for the conversion from one or more entities, and selects a claim corresponding to an entity from the plurality of claims based on the conversion parameter and information included in the plurality of claims. Further, the method transmits information related to the selected claim.

Abstract: The present invention relates to use of ?-glucan extracts in the immunopotentiation of an avian animal Specifically, the present invention provides a kit, wherein the kit comprises (1) an immunopotentiator used for immunopotentiation of an avian animal, wherein the immunopotentiator comprises a ?-glucan extract which is extracted from Saccharomyces cerevisiae cell wall; and (2) a virus vaccine. The present invention also provides use of a ?-glucan extract which is extracted from Saccharomyces cerevisiae cell wall, in the preparation of a kit used for immunopotentiation of an avian animal and immunopotentiator.

Abstract: The present teaching relates to method and system for advertising. The method obtains information related to an operational smart attribution evaluation package (SAEP) posted on a platform. The SAEP is related to a conversion associated with an advertisement displayed by a plurality of entities. The method parses the SAEP to obtain a conversion parameter, and generates a claim for the conversion based on the conversion parameter and information related to the advertisement, if the advertisement was previously displayed. Further, the method transmits the generated claim to the SAEP to be evaluated whether a reward is to be allocated.

Abstract: The present teaching relates to a method and a system for advertising. The method obtains information about a conversion associated with an advertisement and generates with respect to the conversion, an operational smart attribution evaluation package (SAEP). The SAEP includes a conversion parameter and a reward. The method transmits the SAEP to a platform to be posted, and thereafter receives from the SAEP, an indication of an entity which is estimated to be associated with the conversion and to which the reward is to be allocated. The entity is determined by the SAEP based on the conversion parameter and information from a plurality of entities that displayed the advertisement.

Abstract: The present teaching relates to method and system for evaluating a conversion. The method extracts meta-information including a conversion parameter and a reward. The meta-information corresponds to a conversion associated with an advertisement displayed previously by a plurality of entities. The method receives a plurality of claims for the conversion from one or more entities, and selects a claim corresponding to an entity from the plurality of claims based on the conversion parameter and information included in the plurality of claims. Further, the method transmits information related to the selected claim.

Abstract: Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as Cyp8b1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for diabetes and cardiovascular disease.

Abstract: Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as Cyp8b1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for diabetes and cardiovascular disease.

Abstract: The present invention relates to compounds of formula (I), which inhibit acetyl-CoA carboxylase (ACC) and are useful for the prevention or treatment of metabolic syndrome, type II diabetes, obesity, atherosclerosis and cardiovascular diseases in humans.

Abstract: Antibacterials having formula (I) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates used in the processes, compositions containing the compounds, and methods of prophylaxis and treatment of bacterial infections using the compounds are disclosed.

Abstract: The present invention relates to compounds of formula (I), which inhibit acetyl-CoA carboxylase (ACC) and are useful for the prevention or treatment of metabolic syndrome, type II diabetes, obesity, atherosclerosis and cardiovascular diseases in humans.

Abstract: The present invention relates to compounds that activate AMP-activated protein kinase (AMPK), including the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders such as diabetes, metabolic syndrome, and obesity.

Abstract: The present invention relates to compounds that activate AMP-activated protein kinase (AMPK), including the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders such as diabetes, metabolic syndrome, and obesity.

Abstract: The present invention relates to compounds of formula (I), which inhibit acetyl-CoA carboxylase (ACC) and are useful for the prevention or treatment of metabolic syndrome, type II diabetes, obesity, atherosclerosis and cardiovascular diseases in humans.

Abstract: The present invention relates to compounds that activate AMP-activated protein kinase (AMPK), including the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders such as diabetes, metabolic syndrome, and obesity.

Abstract: Antibacterials having formula (I) 1